ReShape Lifesciences Inc. Annual Operating Income (Loss) in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
ReShape Lifesciences Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2024.
  • ReShape Lifesciences Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$1.7M, a 10.2% increase year-over-year.
  • ReShape Lifesciences Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$7.73M, a 49.8% increase year-over-year.
  • ReShape Lifesciences Inc. annual Operating Income (Loss) for 2024 was -$7.73M, a 49.8% increase from 2023.
  • ReShape Lifesciences Inc. annual Operating Income (Loss) for 2023 was -$15.4M, a 66.8% increase from 2022.
  • ReShape Lifesciences Inc. annual Operating Income (Loss) for 2022 was -$46.4M, a 19.9% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$7.73M +$7.66M +49.8% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-04
2023 -$15.4M +$31M +66.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-04
2022 -$46.4M +$11.5M +19.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 -$57.9M -$45.4M -365% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-17
2020 -$12.5M +$10.8M +46.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 -$23.2M +$13.7M +37.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
2018 -$37M -$2.57M -7.49% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$34.4M -$14.9M -76.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-22
2016 -$19.5M -$4.57M -30.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-05
2015 -$14.9M -$5.09M -51.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-05
2014 -$9.84M Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.